Literature DB >> 32041760

Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome.

Shashank Cheemalavagu1, Sara S McCoy2, Jason S Knight3.   

Abstract

A 50-year-old woman with a history of Crohn's disease treated with adalimumab presented with left hand pain and duskiness. Angiogram showed non-filling of the radial and digital arteries of the hand. Antiphospholipid antibody testing was positive, leading to a diagnosis of antitumour necrosis factor-induced antiphospholipid syndrome. Adalimumab was discontinued, and she was treated with the vitamin K antagonist warfarin and low-dose aspirin. Upon resolution of the antiphospholipid antibodies, she was transitioned to aspirin alone without recurrence of thrombosis. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  biological agents; systemic lupus erythematosus

Mesh:

Substances:

Year:  2020        PMID: 32041760      PMCID: PMC7035862          DOI: 10.1136/bcr-2019-232907

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.

Authors:  T Jonsdottir; J Forslid; A van Vollenhoven; A Harju; S Brannemark; L Klareskog; R F van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2004-04-05       Impact factor: 19.103

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  Infliximab-Induced Lupus: A Case Report.

Authors:  Vítor Magno Pereira; Carla Andrade; Ricardo Figueira; Goreti Faria; Luís Jasmins
Journal:  GE Port J Gastroenterol       Date:  2016-11-19

4.  Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state.

Authors:  Jakub Swadzba; Teresa Iwaniec; Jacek Musial
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

Review 5.  The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease.

Authors:  Bengt Fadeel; Ding Xue
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Sep-Oct       Impact factor: 8.250

Review 6.  Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature.

Authors:  Iman Hemmati; Jason Kur
Journal:  Clin Rheumatol       Date:  2013-04-05       Impact factor: 2.980

7.  Arterial and venous thromboembolic events during anti-TNF therapy: a study of 85 spontaneous reports in the period 2000-2006.

Authors:  Nadine Petitpain; Nicolas Gambier; Denis Wahl; Isabelle Chary-Valckenaere; Damien Loeuille; Pierre Gillet
Journal:  Biomed Mater Eng       Date:  2009       Impact factor: 1.300

Review 8.  Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation.

Authors:  Anush Martirosyan; Rustam Aminov; Gayane Manukyan
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

9.  Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.

Authors:  Francesca Bobbio-Pallavicini; Claudia Alpini; Roberto Caporali; Stefano Avalle; Serena Bugatti; Carlomaurizio Montecucco
Journal:  Arthritis Res Ther       Date:  2004-04-26       Impact factor: 5.156

10.  Possible association of etanercept, venous thrombosis, and induction of antiphospholipid syndrome.

Authors:  Shanti Virupannavar; Anthony Brandau; Carla Guggenheim; Heather Laird-Fick
Journal:  Case Rep Rheumatol       Date:  2014-05-15
View more
  2 in total

Review 1.  Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders.

Authors:  Saion Chatterjee; John D Pauling
Journal:  Clin Rheumatol       Date:  2020-09-21       Impact factor: 2.980

2.  16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.

Authors:  Hannah Cohen; Maria J Cuadrado; Doruk Erkan; Ali Duarte-Garcia; David A Isenberg; Jason S Knight; Thomas L Ortel; Anisur Rahman; Jane E Salmon; Maria G Tektonidou; David J Williams; Rohan Willis; Scott C Woller; Danieli Andrade
Journal:  Lupus       Date:  2020-10       Impact factor: 2.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.